Yann Leverrier

Yann Leverrier

Auto-generated profile, based on publicly available information

Yann Leverrier

Universite Claude Bernard Lyon 1, Centre International de Recherche en Infectiologie, Inserm U1111, CNRS UMR5308, École Normale Supérieure de Lyon, Lyon, France

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2001 in Journal of Cell Biology
Verified
Journal Article
Open access
PHPeter R. Hoffmann
Peter R. Hoffmann
ADAimee M. Decathelineau
Aimee M. Decathelineau
COCarol Anne Ogden
Carol Anne Ogden
YLYann Leverrier
Yann Leverrier
DBDonna L. Bratton
Donna L. Bratton
PHPeter M. Henson
Peter M. Henson
Efficient phagocytosis of apoptotic cells is important for normal tissue development, homeostasis, and the resolution of inflammation. Although many receptors have been implicated in the clearance of apoptotic cells, the roles of these receptors in the engulfment process have not been well defined. We developed a novel system to distinguish between receptors involved in tethering of apoptotic cells versus those inducing their uptake. Our results suggest that regardless of the receptors engaged on the phagocyte, ingestion does not occur in the absence of phosphatidylserine (PS). Further, recognition of PS was found to be dependent on the presence of the PS receptor (PSR). Both PS and anti-PSR antibodies stimulated membrane ruffling, vesicle formation, and “bystander” uptake of cells bound to the surface of the phagocyte. We propose that the phagocytosis of apoptotic cells requires two events: tethering followed by PS-stimulated, PSR-mediated macropinocytosis.

1 February 2001 in Current Biology
Verified
Journal Article
Closed access
YLYann Leverrier
Yann Leverrier
ARAnne J. Ridley
Anne J. Ridley

1 January 2013 in Metallomics
Verified
Journal Article
Open access
PDF file
VBVincent Balter
Vincent Balter
ALAline Lamboux
Aline Lamboux
AZAntoine Zazzo
Antoine Zazzo
PTPhilippe Télouk
Philippe Télouk
YLYann Leverrier
Yann Leverrier
FAFrancis Albarède
Francis Albarède
We report Cu, Fe, and Zn natural isotope compositions in organs, body fluids, diets and feces of mice and sheep. Large and systematic isotope variabil

15 April 2001 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YLYann Leverrier
Yann Leverrier
RLRoberto Lorenzi
Roberto Lorenzi
MBMichael P. Blundell
Michael P. Blundell
PBPaul Brickell
Paul Brickell
CKChristine Kinnon
Christine Kinnon
ATAdrian J. Thrasher
Adrian J. Thrasher
Phagocytosis of apoptotic cells by macrophages and dendritic cells is necessary for clearance of proinflammatory debris and for presentation of viral, tumor, and self Ags. While a number of receptors involved in the cognate recognition of apoptotic cells by phagocytes have been identified, the signaling events that result in internalization remain poorly understood. Here we demonstrate that clearance of apoptotic cells is accompanied by recruitment of the Wiskott-Aldrich syndrome (WAS) protein to the phagocytic cup and that it’s absence results in delayed phagocytosis both in vitro and in vivo. Therefore, we propose that WAS protein plays an important and nonredundant role in the safe removal of apoptotic cells and that deficiency contributes significantly to the immune dysregulation of WAS. The efficiency of apoptotic cell clearance may be a key determinant in the suppression of tissue inflammation and prevention of autoimmunity.

22 May 2006 in Oncogene
Verified
Journal Article
Closed access
EDE Deniaud
E Deniaud
JBJ Baguet
J Baguet
AMA-L Mathieu
A-L Mathieu
GPG Pagès
G Pagès
JMJ Marvel
J Marvel
YLY Leverrier
Y Leverrier

15 September 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EDEmmanuelle Deniaud
Emmanuelle Deniaud
JBJoël Baguet
Joël Baguet
RCRoxane Chalard
Roxane Chalard
BBBariza Blanquier
Bariza Blanquier
LBLilia Brinza
Lilia Brinza
YLYann Leverrier
Yann Leverrier
The ubiquitous transcription factor Sp1 regulates the expression of a vast number of genes involved in many cellular functions ranging from differentiation to proliferation and apoptosis. Sp1 expression levels show a dramatic increase during transformation and this could play a critical role for tumour development or maintenance. Although Sp1 deregulation might be beneficial for tumour cells, its overexpression induces apoptosis of untransformed cells. Here we further characterised the functional and transcriptional responses of untransformed cells following Sp1 overexpression. We made use of wild-type and DNA-binding-deficient Sp1 to demonstrate that the induction of apoptosis by Sp1 is dependent on its capacity to bind DNA. Genome-wide expression profiling identified genes involved in cancer, cell death and cell cycle as being enriched among differentially expressed genes following Sp1 overexpression. In silico search to determine the presence of Sp1 binding sites in the promoter region of modulated genes was conducted. Genes that contained Sp1 binding sites in their promoters were enriched among down-regulated genes. The endogenous sp1 gene is one of the most down-regulated suggesting a negative feedback loop induced by overexpressed Sp1. In contrast, genes containing Sp1 binding sites in their promoters were not enriched among up-regulated genes. These results suggest that the transcriptional response involves both direct Sp1-driven transcription and indirect mechanisms. Finally, we show that Sp1 overexpression led to a modified expression of G1/S transition regulatory genes such as the down-regulation of cyclin D2 and the up-regulation of cyclin G2 and cdkn2c/p18 expression. The biological significance of these modifications was confirmed by showing that the cells accumulated in the G1 phase of the cell cycle before the onset of apoptosis. This study shows that the binding to DNA of overexpressed Sp1 induces an inhibition of cell cycle progression that precedes apoptosis and a transcriptional response targeting genes containing Sp1 binding sites in their promoter or not suggesting both direct Sp1-driven transcription and indirect mechanisms.